Xiaowei Zhan

University of Texas Southwestern Medical Center
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (11)

Year:

2026

Year:

2026

Year:

2026

Summary The Microbiome Community Detector (MiCoDe) software is a free user-friendly web tool that is designed to cluster a network of microbial taxa into communities using a Bayesian weighted stochastic block model. MiCoDe also filters the data automatically and accounts for the challenges of microbiome high-throughput sequencing data including high-dimensionality, compositionality, zero inflation, and nonlinearity. While MiCoDe is based on a rigorous statistical unsupervised learning model, our web tool can be easily used by any investigator. Users simply upload a csv file that contains their taxonomic abundance data where rows correspond to samples and columns correspond to taxa. Then, users make a few selections regarding data transformation, network estimation, and the number of communities in order to run the online analysis. If users are unsure of what selections to make, then they can opt for the default settings as these are our recommended settings. In this paper, we discuss the motivation, methodology, implementation, and results of MiCoDe. We also discuss how MiCoDe can be adapted by the user and how it may evolve over time. Our software is a valuable tool for microbiome community detection. Availability and implementation MiCoDe is freely available online at https://lce.biohpc.swmed.edu/micode/, does not require installation, and is not browser-specific. Users can also work locally using our R code, which is freely available on GitHub at https://github.com/klutz920/MiCoDe.

Year:

2025

Precision probiotics have shown great promise as novel therapies but have not been fully realized. One major obstacle is that different strains of the same gut microbiota species can induce markedly variable phenotypic outcomes. Here, we aimed to optimize and validate in a preclinical model, a six-species precision probiotic therapy for graft-versus-host disease (GVHD), an autoimmune complication following allogeneic stem cell transplantation. We had identified these six species as associated with protection against GVHD in a prior clinical study. We isolated strains of three of the targeted taxa (B. longum, C. bolteae, and Blautia spp.) from human stem cell transplant patients and characterized their SCFA production in vitro. We observed significant strain-to-strain variability among these gut microbiota taxa in their capacity to produce short-chain fatty acids, a microbiota-derived metabolite shown to be important for mitigating gut GVHD and inflammatory bowel disease, in vitro. We found that B. longum was able to augment butyrate production by C. bolteae and Blautia when co-cultured in vitro. “Optimized” precision probiotics mitigated GVHD and significantly increased survival (p = 0.013, log-rank test) in mice compared to a “standard” probiotic consortium of the same bacterial species obtained from a commercial repository. Importantly, the optimized probiotics resulted in significant increases in intestinal short-chain fatty acid concentrations compared to standard probiotics (p < 0.001, Mann–Whitney test). Our findings highlight the promising potential of utilizing an optimized precision probiotic approach to maximize therapeutic efficacy.

Year:

2025

The interaction between human leukocyte antigens (HLAs) and T cell receptor (TCR) is essential for adaptive immune recognition. While it is known that one TCR can map to multiple HLA alleles, the extent of this cross-reactivity remains poorly understood. Here, we introduce THNet, a TCR-based HLA similarity network, and present a comprehensive analysis of HLA-TCR cross-reactivity, which is built upon more than 9 million significantly associated HLA-TCR pairs. We created similarity networks for both class I and class II HLA alleles, illustrating how peptide cross-presentation contributes to HLA-TCR cross-reactivity. Our analysis revealed disease susceptibilities missed by single-HLA enrichment analyses, especially in the Black population. Last, we demonstrated that THNet can prioritize optimal HLA mismatch candidates across different transplantation contexts, supporting its potential utility in donor selection strategies. In summary, our investigation of the HLA-TCR cross-reactive network provides useful insights into autoimmune risk prediction and improved transplantation outcomes.

Year:

2025

Background Spatially resolved profiling technologies to quantify transcriptomes, epigenomes, and proteomes have been emerging as groundbreaking methods for comprehensive molecular characterizations. Dimensionality reduction and visualization is an essential step to analyze and interpret spatially resolved profiling data. However, state-of-the-art dimensionality reduction methods for single-cell sequencing data, such as the t-distributed stochastic neighbor embedding (t-SNE) and uniform manifold approximation and projection (UMAP), were not tailored for spatially resolved profiling data. Results Here we developed a spatially resolved t-SNE (SpaSNE) method to integrate both spatial and molecular information. We applied it to a variety of public spatially resolved profiling datasets that were generated from 3 experimental platforms and consisted of cells from different diseases, tissues, and cell types. To compare the performances of SpaSNE, t-SNE, and UMAP, we applied them to 4 spatially resolved profiling datasets obtained from 3 distinct experimental platforms (Visium, STARmap, and MERFISH) on both diseased and normal tissues. Comparisons between SpaSNE and these state-of-the-art approaches reveal that SpaSNE achieves more accurate and meaningful visualization that better elucidates the underlying spatial and molecular data structures. Conclusions This work demonstrates the broad application of SpaSNE for reliable and robust interpretation of cell types based on both molecular and spatial information, which can set the foundation for many subsequent analysis steps, such as differential gene expression and trajectory or pseudotime analysis on the spatially resolved profiling data.

Year:

2025

Year:

2025

Background/Objectives: Preterm infants often require increased caloric intake to maintain appropriate growth while in the neonatal intensive care unit (NICU). Emerging evidence suggests that alterations of the gut microbiome may play a role in infant and childhood growth patterns. The fecal microbiome patterns in infants with normal and poor growth patterns were classified in this study. Methods: We conducted a prospective trial of infants of less than 29 weeks’ gestation with an embedded case–control analysis of infants with normal or poor growth patterns. Fecal samples were collected weekly from infants on full enteral feeds and analyzed blindly using 16s rRNA next-generation sequencing. The relationship between gut microbial diversity and composition and growth pattern and trajectory were assessed. Results: A total of 115 infants were enrolled in the trial with 263 fecal samples selected from 87 enrolled infants for analysis. In total, 37 samples were available from the normal growth cohort, 56 samples from the poor growth cohort, and 170 samples were available for analysis from the very poor growth cohort. Analysis of relative abundance revealed increased representation of Veillonella, Bifidobacterium, and Clostridium in very poor growth infants compared to normal growth infants. Variation in specific taxa was also found to vary significantly across post-menstrual age depending on the degree of growth failure. Conclusions: Gut microbiome composition and variance was modified by the degree of growth failure in our cohort of preterm infants. Our study adds to the growing body of evidence that alteration of the microbiome is associated with poor growth in preterm infants. This may ultimately represent a therapeutic target for growth failure in preterm infants.

Year:

2025

Identifying how drug molecular structures interact with specific gene targets remains a key challenge in cancer precision medicine. Although large-scale in vitro drug screening datasets are available, most computational models fail to elucidate the molecular mechanisms underlying drug-gene interactions or inform mechanisms of action (MOA). Here, we present MIDI (Mechanism-Interpretable Drug-Gene Interaction), a novel, attention-guided, mechanism-aware deep learning framework designed to address this gap. MIDI is trained on 80% of cell lines from the Cancer Cell Line Encyclopedia (CCLE) and evaluated on the remaining 20%, demonstrating improved drug response prediction performance over existing benchmarks. Leveraging chemical structure information, MIDI incorporates a Graphformer-based self-attention mechanism to capture atomic-level interactions between small molecules and gene features. A cross-attention module further enables the model to map drug structures to candidate gene targets, supporting interpretable mechanistic inference. To simulate a realistic in silico drug screening scenario, we evaluated MIDI on 52 previously unseen drugs from the Genomics of Drug Sensitivity in Cancer (GDSC) dataset. MIDI consistently ranked true gene targets among the top candidates across thousands of possibilities. These results highlight the feasibility and utility of in silico drug screening with MIDI, enabling both predictive modeling and mechanistic exploration. By uncovering interpretable drug-gene relationships, MIDI provides a scalable, data-driven framework to accelerate therapeutic discovery and target prioritization in preclinical research.

Year:

2025

Year:

2023

Collaborators (13)

Dajiang Liu

University Distinguished Professor

Penn State College of Medicine

UNITED STATES
View details

Nancy Olsen

Professor

-

UNITED STATES
View details

D. E. Greenberg

University of Texas Southwestern Medical Center

UNITED STATES
View details

Lin Xu

Assistant Professor (tenure track)

University of Texas Southwestern Medical School

UNITED STATES
View details

Nicole De Nisco

Assistant Professor

University of Texas at Dallas

UNITED STATES
View details

Qiwei Li

Associate Professor

University of Texas at Dallas

UNITED STATES
View details

Kevin C Lutz

Assistant Professor

University of Texas Southwestern Medical Center

UNITED STATES
View details

Andrew Y. Koh

Professor and Division Chief

University of Texas Southwestern Medical Center

UNITED STATES
View details

qin zhou

Southwestern Medical Center

UNITED STATES
View details

Tao Wang

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Bo Li

University of Pennsylvania

UNITED STATES
View details

Guanghua Xiao

-

UNITED STATES
View details

Yang Xie

Professor

University of Texas Southwestern Medical Center

UNITED STATES
View details